MedTrace Logo

A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients

NCT02129686 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2026-04-07

No results posted yet for this study

Summary

This study is being done to evaluate the potential benefits of using acupuncture to reduce symptoms of tingling, burning, numbness and pain in the hands and feet of women with peripheral neuropathy after completion of chemotherapy for breast cancer.

Conditions

  • Taxane-induced Peripheral Neuropathy
  • Chemotherapy-induced Peripheral Neuropathy (CIPN)
  • Early-Stage Breast Carcinoma
  • Stage I Breast Cancer
  • Stage II Breast Cancer
  • Stage III Breast Cancer

Interventions

PROCEDURE

Immediate Acupuncture Group

PROCEDURE

Delayed Acupuncture Group

Sponsors & Collaborators

Principal Investigators

  • Weidong Lu, M.B., MPH, Ph.D · Dana-Farber Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-01
Primary Completion
2016-09-15
Completion
2021-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02129686 on ClinicalTrials.gov